Clinical Cardiology Alert – March 1, 2011

March 1, 2011

• Eplerenone Use for Mild Symptomatic Heart Failure?

  Mineralocorticoid receptor blockers have demonstrated improved survival in class III-IV heart-failure patients (spironolactone) and post-acute myocardial infarction patients with systolic dysfunction heart failure (eplerenone).

  Read more

• Performing Cardioversion: Dabigatran Therapy vs. Warfarin

  The randomized evaluation of long-term anticoagulation Therapy (RE-LY) trial was a study that compared two doses of a new direct-thrombin inhibitor, dabigatran, to warfarin for stroke prevention in patients with atrial fibrillation.

  Read more

• Five-year Follow-up of Atrial Fibrillation Ablation

  Most prior study results of catheter ablation for atrial fibrillation (AF) have had relatively short follow-up duration.

  Read more

• Prosthetic Valve Thrombosis — Urgent Surgery or Thrombolysis?

  Thrombosis of prosthetic heart valves is one of the most feared complications of heart-valve replacement.

  Read more

• Anomalous Coronary Arteries from the Opposite Coronary Sinus: Similar Long-term Outcomes from Medical or Surgical Treatment

  Coronary artery anomalies are being recognized with increasing frequency due to the increased usage of computed tomography (CT) and magnetic resonance imaging (MRI) scans in patients with chest pain syndromes.

  Read more

• Clinical Briefs in Primary Care Supplement

  Read more

• Pharmacology Watch

  Escitalopram for menopausal hot flashes, rifaximin for IBS without constipation, herpes zoster vaccination, antiepileptics drugs and fracture risk, and FDA Actions.

  Read more